Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1108693

	registered interest
	date	01/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions his Department has had with NICE on the prescription of medicinal cannabis oil for patients with (a) cerebral palsy and (b) arthritis.
	tabling member constituency	Banff and Buchan
	tabling member printed	David Duguid
	uin	239283
	answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>The Department has not discussed with the National Institute for Health and Care Excellence (NICE) the prescription of medicinal cannabis oil for patients with cerebral palsy and arthritis.</p><p> </p><p>NICE is the independent expert body that develops authoritative, evidence-based guidance for the National Health Service on whether drugs and other treatments represent a clinically and cost effective use of NHS resources. NICE is developing guidance on the prescribing of cannabis-based medicinal products by October 2019. It will be based on the best available international evidence and will have been produced using NICE’s world-renowned process for delivering such guidance.</p><p> </p><p>Following a public consultation on the draft scope, the guidance will focus on the use of cannabis-based products in the treatment of chronic pain, intractable nausea and vomiting, spasticity and severe treatment-resistant epilepsy, conditions where the evidence is currently most advanced. A consultation on the draft guidance is expected in the summer.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 09/04/2019 14:41:04 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4606 label Biography information for David Duguid

1108996

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Travellers and Homelessness
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps (a) his Department plans to take with the NHS to respond to the findings of the Friends Families and Travellers’ report entitled No room at the inn: How easy is it for nomadic Gypsies and Travellers to access primary care and (b) the NHS plans to take to ensure homeless people can access healthcare at any GP practice they choose.
	tabling member constituency	Bermondsey and Old Southwark
	tabling member printed	Neil Coyle
	uin	240011
	answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>Registering with and access to primary medical care services is the same for all patients, whether they are gypsies, travellers, or homeless people. People do not need to provide proof of address to register with a general practice (GP). NHS England is working with a range of community groups to redesign the patient registration leaflet so that people are aware of this when registering. The free NHS 111 service can assist anyone who has faced difficulty finding a GP or accessing other services in their local area.</p><p> </p><p>NHS England is aware of difficulties some individuals have faced when trying to register with a GP and is taking steps to address shortcomings with individual practices, working in partnership with the voluntary sector.</p><p> </p><p>The Voluntary, Community and Social Enterprise Health and Wellbeing Alliance is a partnership arrangement with the aim to facilitate integrated working between the voluntary and statutory sectors, to promote equality and reduce health inequalities. It receives £1.2 million for core work from the Department, with each member receiving funding of up to £60,000. Families and Travellers is a member of the Alliance and have supported the Department on a range of work to date including the Inclusion Health Audit Tool, on maternal health, mental health, end of life care and dementia.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 09/04/2019 14:33:43 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4368 label Biography information for Neil Coyle

1109014

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Obesity
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to increase access to Tier 3 obesity services.
	tabling member constituency	St Ives
	tabling member printed	Derek Thomas
	uin	240051
	answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>Public Health England has been working with NHS England to support approaches to obesity as part of the NHS Long Term Plan. The NHS Long Term Plan has a number of different actions to support the drive to reduce obesity, including investment in tier 3 services for both children and adults and plans are in development for this expansion. This will result in, for example, a further 1,000 children a year being treated by 2022/23 for severe complications related to obesity.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 09/04/2019 14:35:00 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4532 label Biography information for Derek Thomas

1109016

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Obesity
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he has taken to establish the cost of obesity to the (a) NHS, (b) social services and (c) the wider economy.
	tabling member constituency	St Ives
	tabling member printed	Derek Thomas
	uin	240052
	answer	answer is ministerial correction date of answer 10/04/2019 answer text <p>‘The economic burden of ill health due to diet, physical inactivity, smoking, alcohol and obesity in the UK: an update to 2006-07 NHS costs’ estimated that overweight and obesity cost the National Health Service in the United Kingdom £5.1 billion per year. This figure was uplifted to £6.1 billion in 2014/15 to take account of inflation.</p><p> </p><p>The Foresight team published ‘Tackling Obesities: Future Choices in 2007’. This estimated the annual costs of overweight and obesity to society and the economy as £27 billion in 2015, based on obesity prevalence at the time. In 2014 the McKinsey Global Institute estimated the cost of obesity to the UK economy as £46 billion per year.</p><p> </p><p>No further estimates of the costs of obesity are planned or have been made centrally.</p><p> </p><p>Copies of ‘The economic burden of ill health due to diet, physical inactivity, smoking, alcohol and obesity in the UK: an update to 2006-07 NHS costs’; ‘Tackling Obesities: Future Choices’; and the McKinsey Global Institute’s report ‘Overcoming obesity: An initial economic analysis’ are available at the following links:</p><p> </p><p><a href="https://academic.oup.com/jpubhealth/article/33/4/527/1568587" target="_blank">https://academic.oup.com/jpubhealth/article/33/4/527/1568587</a></p><p> </p><p><a href="https://www.gov.uk/government/publications/reducing-obesity-future-choices" target="_blank">https://www.gov.uk/government/publications/reducing-obesity-future-choices</a></p><p> </p><p><a href="http://www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/how-the-world-could-better-fight-obesity" target="_blank">www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/how-the-world-could-better-fight-obesity</a></p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 240053 question first answered 10/04/2019 13:47:01 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4532 label Biography information for Derek Thomas

1109017

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Obesity
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the cost of obesity to the (a) NHS, (b) social services and (c) wider economy.
	tabling member constituency	St Ives
	tabling member printed	Derek Thomas
	uin	240053
	answer	answer is ministerial correction date of answer 10/04/2019 answer text <p>‘The economic burden of ill health due to diet, physical inactivity, smoking, alcohol and obesity in the UK: an update to 2006-07 NHS costs’ estimated that overweight and obesity cost the National Health Service in the United Kingdom £5.1 billion per year. This figure was uplifted to £6.1 billion in 2014/15 to take account of inflation.</p><p> </p><p>The Foresight team published ‘Tackling Obesities: Future Choices in 2007’. This estimated the annual costs of overweight and obesity to society and the economy as £27 billion in 2015, based on obesity prevalence at the time. In 2014 the McKinsey Global Institute estimated the cost of obesity to the UK economy as £46 billion per year.</p><p> </p><p>No further estimates of the costs of obesity are planned or have been made centrally.</p><p> </p><p>Copies of ‘The economic burden of ill health due to diet, physical inactivity, smoking, alcohol and obesity in the UK: an update to 2006-07 NHS costs’; ‘Tackling Obesities: Future Choices’; and the McKinsey Global Institute’s report ‘Overcoming obesity: An initial economic analysis’ are available at the following links:</p><p> </p><p><a href="https://academic.oup.com/jpubhealth/article/33/4/527/1568587" target="_blank">https://academic.oup.com/jpubhealth/article/33/4/527/1568587</a></p><p> </p><p><a href="https://www.gov.uk/government/publications/reducing-obesity-future-choices" target="_blank">https://www.gov.uk/government/publications/reducing-obesity-future-choices</a></p><p> </p><p><a href="http://www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/how-the-world-could-better-fight-obesity" target="_blank">www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/how-the-world-could-better-fight-obesity</a></p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 240052 question first answered 10/04/2019 13:47:01 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4532 label Biography information for Derek Thomas

1109018

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Obesity
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 27 March 2018 to Question 133501 on obesity, for what reason his Department does not hold information on the number of tier three obesity services commissioned by clinical commissioning groups or local authorities; and whether he plans to collate that information.
	tabling member constituency	St Ives
	tabling member printed	Derek Thomas
	uin	240054
	answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>It would not be cost-effective for the Department to collect data on every clinical intervention, including information on tier three obesity services commissioned by clinical commissioning groups or local authorities.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 09/04/2019 14:36:07 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4532 label Biography information for Derek Thomas

1109022

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sterilisation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many Clinical Commissioning Groups commission vasectomy services for patients who are not in exceptional circumstances.
	tabling member constituency	Oxford East
	tabling member printed	Anneliese Dodds
	uin	240100
	answer	answer is ministerial correction date of answer 08/04/2019 answer text <p>This is a matter for local clinical commissioning groups, and the information requested is not held centrally by the Department or NHS England.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 08/04/2019 15:26:41 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4657 label Biography information for Anneliese Dodds

1109030

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Orthopaedics
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for his policies of the conclusions of the All-Party Parliamentary Group on Vascular and Venous Disease report entitled Saving Limbs, Saving Lives: A Call to Action to Reduce Inequalities in Lower Limb Amputation Rates; and if he will make a statement.
	tabling member constituency	St Ives
	tabling member printed	Derek Thomas
	uin	240055
	answer	answer is ministerial correction date of answer 10/04/2019 answer text <p>The specialised commissioning Clinical Reference Group (CRG) for Vascular Disease, together with NHS Improvement’s Getting it Right First Time (GIRFT) team, aims to address many of the issues raised in the report. There is a joint NHS England and GIRFT Board for the ‘Action on Vascular’ work, which is focusing on the early availability of treatments to increase lower limb circulation and reduce amputation rates.</p><p> </p><p>The NHS Long Term Plan published on 7 January commits to ensuring that hospitals provide patients with access to multi-disciplinary footcare teams and inpatient specialist nursing teams, in order to improve recovery and reduce lengths of stay and future readmissions. This commitment will support reducing inequalities by giving universal access to multi-disciplinary footcare teams and diabetes inpatient specialist nurses.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 240056 question first answered 10/04/2019 13:38:19 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4532 label Biography information for Derek Thomas

1109031

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Orthopaedics
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the report from the All-Party Parliamentary Group on Vascular and Venous Disease entitled Saving Limbs, Saving Lives: A Call to Action to Reduce Inequalities in Lower Limb Amputation Rates, what steps he will take to address disparities in amputation rates throughout the UK.
	tabling member constituency	St Ives
	tabling member printed	Derek Thomas
	uin	240056
	answer	answer is ministerial correction date of answer 10/04/2019 answer text <p>The specialised commissioning Clinical Reference Group (CRG) for Vascular Disease, together with NHS Improvement’s Getting it Right First Time (GIRFT) team, aims to address many of the issues raised in the report. There is a joint NHS England and GIRFT Board for the ‘Action on Vascular’ work, which is focusing on the early availability of treatments to increase lower limb circulation and reduce amputation rates.</p><p> </p><p>The NHS Long Term Plan published on 7 January commits to ensuring that hospitals provide patients with access to multi-disciplinary footcare teams and inpatient specialist nursing teams, in order to improve recovery and reduce lengths of stay and future readmissions. This commitment will support reducing inequalities by giving universal access to multi-disciplinary footcare teams and diabetes inpatient specialist nurses.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 240055 question first answered 10/04/2019 13:38:19 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4532 label Biography information for Derek Thomas

1109054

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cytomegalovirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to improve the (a) diagnosis and (b) treatment of cytomegalovirus in infants and children.
	tabling member constituency	Glasgow East
	tabling member printed	David Linden
	uin	240083
	answer	answer is ministerial correction date of answer 10/04/2019 answer text <p>Experts advise that cytomegalovirus (CMV) remains difficult to diagnose because in the majority of cases the baby presents normally at birth.</p><p> </p><p>In 2017, the Royal College of Obstetricians and Gynaecology (RCOG) published an update for the treatment of congenital CMV infection, acknowledging that therapeutic options such as antiviral therapy are still being evaluated within the research setting. The RCOG will consider whether the paper needed to be updated.</p><p> </p><p>Departmental officials will be meeting the charity CMV Action next month to discuss their recommendations to prevent, diagnose and intervene.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/04/2019 13:32:18 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4640 label Biography information for David Linden

1109055

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cytomegalovirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to increase (a) awareness of and (b) education on cytomegalovirus among parents and children.
	tabling member constituency	Glasgow East
	tabling member printed	David Linden
	uin	240084
	answer	answer is ministerial correction date of answer 10/04/2019 answer text <p>Health visitors and midwives, together with other health care professionals including general practitioners and general practice nurses provide advice and guidance to families at contacts in the pre-conception period, pregnancy and throughout early childhood.</p><p> </p><p>To support direct clinical advice from health care professionals, Public Health England’s Start4Life social marketing programme informs parents-to-be and parents about cytomegalovirus via its Information Service for Parents subscription email service. This includes links to the National Health Service website, and information on preventative measures, including good hand hygiene. Start4Life also provides this messaging through its social media channels.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 240085 question first answered 10/04/2019 13:42:07 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4640 label Biography information for David Linden

1109056

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cytomegalovirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to increase (a) awareness of and (b) education on cytomegalovirus among pregnant women.
	tabling member constituency	Glasgow East
	tabling member printed	David Linden
	uin	240085
	answer	answer is ministerial correction date of answer 10/04/2019 answer text <p>Health visitors and midwives, together with other health care professionals including general practitioners and general practice nurses provide advice and guidance to families at contacts in the pre-conception period, pregnancy and throughout early childhood.</p><p> </p><p>To support direct clinical advice from health care professionals, Public Health England’s Start4Life social marketing programme informs parents-to-be and parents about cytomegalovirus via its Information Service for Parents subscription email service. This includes links to the National Health Service website, and information on preventative measures, including good hand hygiene. Start4Life also provides this messaging through its social media channels.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 240084 question first answered 10/04/2019 13:42:07 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4640 label Biography information for David Linden

1109060

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cytomegalovirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the costs incurred to NHS England each year of treating cytomegalovirus.
	tabling member constituency	Glasgow East
	tabling member printed	David Linden
	uin	240088
	answer	answer is ministerial correction date of answer 10/04/2019 answer text <p>This information is not held centrally. The range of procedures and diagnoses that may cover cytomegalovirus mean it is not possible to provide a cost of treatment.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/04/2019 13:50:04 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4640 label Biography information for David Linden

1109066

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pancreatic Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase the survival rate of patients with pancreatic cancer.
	tabling member constituency	Coventry South
	tabling member printed	Mr Jim Cunningham
	uin	239856
	answer	answer is ministerial correction date of answer 08/04/2019 answer text <p>Later this year, the Government will begin the roll-out of new Rapid Diagnostic Centres across the country to upgrade and bring together the latest diagnostic equipment and expertise, which focus on diagnosing cancers where patients often present with non-specific symptoms, like pancreatic cancer, and may go to their general practitioner (GP) many times before being sent for tests.</p><p> </p><p>This is part of the NHS Long Term Plan that was published in January 2019. It sets a new ambition that, by 2028, the proportion of cancers diagnosed at stages 1 and 2 will rise from around half now to three-quarters of cancer patients. Achieving this will mean that, from 2028, 55,000 more people each year will survive their cancer for at least five years after diagnosis. We will build on work to raise greater awareness of symptoms of cancer, lower the threshold for referral by GPs, accelerate access to diagnosis and treatment and maximise the number of cancers that we identify through screening. This includes the use of personalised and risk stratified screening and beginning to test the family members of cancer patients where they are at increased risk of cancer.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 08/04/2019 15:28:26 answering member 4455 label Biography information for Seema Kennedy
	tabling member	308 label Biography information for Mr Jim Cunningham

1109073

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Hyperkalaemia
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the prevalence of hyperkalaemia for patients with chronic kidney disease.
	tabling member constituency	Coventry South
	tabling member printed	Mr Jim Cunningham
	uin	239857
	answer	answer is ministerial correction date of answer 08/04/2019 answer text <p>Hyperkalaemia usually occurs in patients with renal impairment which can be acute or chronic. In patients with chronic kidney disease (CKD), several factors increase susceptibility to hyperkalaemia including a high dietary potassium intake relative to residual renal function. When patients with CKD have other risk factors, for example treatment with drugs that interfere with the renin-angiotensin-aldosterone system, the risk of hyperkalaemia is further increased. Clinical presentation of hyperkalaemia is highly variable with some patients presenting with an acute illness whilst others may be asymptomatic.</p><p> </p><p>Although not completely preventable, the risk of developing hyperkalaemia can be reduced. Clinical practice guidelines treatment of acute hyperkalaemia in adults, a collaboration between the Renal Association and Resuscitation Council UK that is endorsed by a range of organisations, including the College of Emergency Medicine and the Faculty of Intensive Care medicine, sets out evidence-based guidance on the management of the condition. It was developed to improve the treatment of acute hyperkalaemia and to reduce the risk of complications associated with hyperkalaemia and its treatment. The main measures in primary prevention in patients with CKD are regular blood monitoring, careful drug prescribing and dietary advice. Patient information and education may reduce the risk of inadvertent hyperkalaemia. The guidance can be found at the following link:</p><p> </p><p><a href="https://renal.org/wp-content/uploads/2017/06/hyperkalaemia-guideline-1.pdf" target="_blank">https://renal.org/wp-content/uploads/2017/06/hyperkalaemia-guideline-1.pdf</a></p><p> </p><p>Information regarding the annual cost to the National Health Service of treating hyperkalaemia in Coventry South and England is not available. This answer covers England only. Funding of such services in the other United Kingdom nations is a matter for the respective devolved administrations.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 239865 question first answered 08/04/2019 15:20:04 answering member 4455 label Biography information for Seema Kennedy
	tabling member	308 label Biography information for Mr Jim Cunningham

1109089

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Packaging
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what proportion of NHS prescription drugs are issued in recyclable packaging.
	tabling member constituency	Portsmouth South
	tabling member printed	Stephen Morgan
	uin	240096
	answer	answer is ministerial correction date of answer 08/04/2019 answer text <p>The information requested is not held centrally.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 08/04/2019 15:27:29 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4653 label Biography information for Stephen Morgan

1109124

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dermatology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps are being taken by (a) his Department, (b) NHS England and (c) NICE to ensure there is a NICE clinical guideline and quality standard in place for atopic dermatitis in adults.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	239946
	answer	answer is ministerial correction date of answer 10/04/2019 answer text <p>NHS England is the principal commissioner of clinical guidelines and National Health Service related quality standards from the National Institute for Health and Care Excellence (NICE).</p><p> </p><p>NICE and NHS England have been in discussion about developing a clinical guideline and quality standard on atopic dermatitis (eczema) in adults. NHS England has recently consulted on a draft policy which included the prescribing of emollient bath and shower preparations for dry and pruritic skin conditions and will consider the appropriateness of referring a guideline on atopic dermatitis in adults to NICE after the consultation responses have been reviewed.</p><p> </p><p>Details of this can be seen in the consultation document at the following link:</p><p> </p><p><a href="https://www.engage.england.nhs.uk/consultation/items-routinely-prescribed-update/user_uploads/low-priority-prescribing-consultation-guidance.pdf" target="_blank">https://www.engage.england.nhs.uk/consultation/items-routinely-prescribed-update/user_uploads/low-priority-prescribing-consultation-guidance.pdf</a></p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 239947 question first answered 10/04/2019 13:28:54 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4056 label Biography information for Nic Dakin

1109125

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dermatology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department supports the prioritisation of atopic dermatitis in adults as a topic for guideline development by NICE.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	239947
	answer	answer is ministerial correction date of answer 10/04/2019 answer text <p>NHS England is the principal commissioner of clinical guidelines and National Health Service related quality standards from the National Institute for Health and Care Excellence (NICE).</p><p> </p><p>NICE and NHS England have been in discussion about developing a clinical guideline and quality standard on atopic dermatitis (eczema) in adults. NHS England has recently consulted on a draft policy which included the prescribing of emollient bath and shower preparations for dry and pruritic skin conditions and will consider the appropriateness of referring a guideline on atopic dermatitis in adults to NICE after the consultation responses have been reviewed.</p><p> </p><p>Details of this can be seen in the consultation document at the following link:</p><p> </p><p><a href="https://www.engage.england.nhs.uk/consultation/items-routinely-prescribed-update/user_uploads/low-priority-prescribing-consultation-guidance.pdf" target="_blank">https://www.engage.england.nhs.uk/consultation/items-routinely-prescribed-update/user_uploads/low-priority-prescribing-consultation-guidance.pdf</a></p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 239946 question first answered 10/04/2019 13:28:54 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4056 label Biography information for Nic Dakin

1109126

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dermatology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure patient experience is at the heart of commissioning for adult atopic dermatitis services in England.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	239948
	answer	answer is ministerial correction date of answer 10/04/2019 answer text <p>The commissioning and configuration of dermatology services in England is a local matter. The majority of patients with dermatological disorders are managed in primary and community care and the local National Health Service is best placed to make decisions that ensure services meet the needs of resident populations in the most appropriate way.</p><p> </p><p>The National Institute for Health and Care Excellence has published guidance on a number of dermatological conditions, including eczema, also known as atopic dermatitis, to support commissioners to plan and deliver services for local populations. ‘Atopic eczema in under 12’s: diagnosis and management’ includes recommendations that healthcare professionals should adopt a holistic approach at each consultation, taking into account severity of a condition and the impact this may have on quality of life.</p><p> </p><p>Healthcare professionals should be aware that all categories of severity of atopic eczema, even mild, can have a negative impact on psychological and psychosocial wellbeing and quality of life and that assessment of wellbeing should be carried out at every consultation. Furthermore, the guidance recommends using validated tools in the management of patients, such as Children's Dermatology Life Quality Index, Infants' Dermatitis Quality of Life Index or Dermatitis Family Impact questionnaire for quality of life. Where quality of life and psychosocial wellbeing has not improved despite treatment and improvement, patients should be referred for psychological advice. The guidance can be found at the following link:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg57" target="_blank">www.nice.org.uk/guidance/cg57</a></p><p> </p><p>As set out in the NHS Long Term Plan, published on 7 January 2019, NHS England is taking action in range of areas to improve the care treatment and support provided to people with long term conditions. As part of this, it is continuing its expansion of Improving Access to Psychological Therapies (IAPT) services for adults with common mental health problems, with a focus on those with long-term conditions. IAPT services have now evolved to deliver benefits to people with long-term conditions, providing genuinely integrated care. By 2023/24, an additional 380,000 adults will be able to access IAPT services.</p><p> </p><p>No assessment has been made on the impact of atopic dermatitis on patient expenses, work days and mental health services. No meetings regarding atopic dermatitis have taken place in the last 12 months.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 239949 239950 239951 question first answered 10/04/2019 13:36:32 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4056 label Biography information for Nic Dakin

1109127

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dermatology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many meetings his Department has had with (a) patient and (b) professional atopic dermatitis groups in the last 12 months.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	239949
	answer	answer is ministerial correction date of answer 10/04/2019 answer text <p>The commissioning and configuration of dermatology services in England is a local matter. The majority of patients with dermatological disorders are managed in primary and community care and the local National Health Service is best placed to make decisions that ensure services meet the needs of resident populations in the most appropriate way.</p><p> </p><p>The National Institute for Health and Care Excellence has published guidance on a number of dermatological conditions, including eczema, also known as atopic dermatitis, to support commissioners to plan and deliver services for local populations. ‘Atopic eczema in under 12’s: diagnosis and management’ includes recommendations that healthcare professionals should adopt a holistic approach at each consultation, taking into account severity of a condition and the impact this may have on quality of life.</p><p> </p><p>Healthcare professionals should be aware that all categories of severity of atopic eczema, even mild, can have a negative impact on psychological and psychosocial wellbeing and quality of life and that assessment of wellbeing should be carried out at every consultation. Furthermore, the guidance recommends using validated tools in the management of patients, such as Children's Dermatology Life Quality Index, Infants' Dermatitis Quality of Life Index or Dermatitis Family Impact questionnaire for quality of life. Where quality of life and psychosocial wellbeing has not improved despite treatment and improvement, patients should be referred for psychological advice. The guidance can be found at the following link:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg57" target="_blank">www.nice.org.uk/guidance/cg57</a></p><p> </p><p>As set out in the NHS Long Term Plan, published on 7 January 2019, NHS England is taking action in range of areas to improve the care treatment and support provided to people with long term conditions. As part of this, it is continuing its expansion of Improving Access to Psychological Therapies (IAPT) services for adults with common mental health problems, with a focus on those with long-term conditions. IAPT services have now evolved to deliver benefits to people with long-term conditions, providing genuinely integrated care. By 2023/24, an additional 380,000 adults will be able to access IAPT services.</p><p> </p><p>No assessment has been made on the impact of atopic dermatitis on patient expenses, work days and mental health services. No meetings regarding atopic dermatitis have taken place in the last 12 months.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 239948 239950 239951 question first answered 10/04/2019 13:36:32 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4056 label Biography information for Nic Dakin

1109128

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dermatology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to support the provision of psychodermatology services across England.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	239950
	answer	answer is ministerial correction date of answer 10/04/2019 answer text <p>The commissioning and configuration of dermatology services in England is a local matter. The majority of patients with dermatological disorders are managed in primary and community care and the local National Health Service is best placed to make decisions that ensure services meet the needs of resident populations in the most appropriate way.</p><p> </p><p>The National Institute for Health and Care Excellence has published guidance on a number of dermatological conditions, including eczema, also known as atopic dermatitis, to support commissioners to plan and deliver services for local populations. ‘Atopic eczema in under 12’s: diagnosis and management’ includes recommendations that healthcare professionals should adopt a holistic approach at each consultation, taking into account severity of a condition and the impact this may have on quality of life.</p><p> </p><p>Healthcare professionals should be aware that all categories of severity of atopic eczema, even mild, can have a negative impact on psychological and psychosocial wellbeing and quality of life and that assessment of wellbeing should be carried out at every consultation. Furthermore, the guidance recommends using validated tools in the management of patients, such as Children's Dermatology Life Quality Index, Infants' Dermatitis Quality of Life Index or Dermatitis Family Impact questionnaire for quality of life. Where quality of life and psychosocial wellbeing has not improved despite treatment and improvement, patients should be referred for psychological advice. The guidance can be found at the following link:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg57" target="_blank">www.nice.org.uk/guidance/cg57</a></p><p> </p><p>As set out in the NHS Long Term Plan, published on 7 January 2019, NHS England is taking action in range of areas to improve the care treatment and support provided to people with long term conditions. As part of this, it is continuing its expansion of Improving Access to Psychological Therapies (IAPT) services for adults with common mental health problems, with a focus on those with long-term conditions. IAPT services have now evolved to deliver benefits to people with long-term conditions, providing genuinely integrated care. By 2023/24, an additional 380,000 adults will be able to access IAPT services.</p><p> </p><p>No assessment has been made on the impact of atopic dermatitis on patient expenses, work days and mental health services. No meetings regarding atopic dermatitis have taken place in the last 12 months.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 239948 239949 239951 question first answered 10/04/2019 13:36:32 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4056 label Biography information for Nic Dakin

1109129

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dermatology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the incidence of atopic dermatitis on (a) patients’ out of pocket expenses, (b) lost work days and (c) mental health services.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	239951
	answer	answer is ministerial correction date of answer 10/04/2019 answer text <p>The commissioning and configuration of dermatology services in England is a local matter. The majority of patients with dermatological disorders are managed in primary and community care and the local National Health Service is best placed to make decisions that ensure services meet the needs of resident populations in the most appropriate way.</p><p> </p><p>The National Institute for Health and Care Excellence has published guidance on a number of dermatological conditions, including eczema, also known as atopic dermatitis, to support commissioners to plan and deliver services for local populations. ‘Atopic eczema in under 12’s: diagnosis and management’ includes recommendations that healthcare professionals should adopt a holistic approach at each consultation, taking into account severity of a condition and the impact this may have on quality of life.</p><p> </p><p>Healthcare professionals should be aware that all categories of severity of atopic eczema, even mild, can have a negative impact on psychological and psychosocial wellbeing and quality of life and that assessment of wellbeing should be carried out at every consultation. Furthermore, the guidance recommends using validated tools in the management of patients, such as Children's Dermatology Life Quality Index, Infants' Dermatitis Quality of Life Index or Dermatitis Family Impact questionnaire for quality of life. Where quality of life and psychosocial wellbeing has not improved despite treatment and improvement, patients should be referred for psychological advice. The guidance can be found at the following link:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg57" target="_blank">www.nice.org.uk/guidance/cg57</a></p><p> </p><p>As set out in the NHS Long Term Plan, published on 7 January 2019, NHS England is taking action in range of areas to improve the care treatment and support provided to people with long term conditions. As part of this, it is continuing its expansion of Improving Access to Psychological Therapies (IAPT) services for adults with common mental health problems, with a focus on those with long-term conditions. IAPT services have now evolved to deliver benefits to people with long-term conditions, providing genuinely integrated care. By 2023/24, an additional 380,000 adults will be able to access IAPT services.</p><p> </p><p>No assessment has been made on the impact of atopic dermatitis on patient expenses, work days and mental health services. No meetings regarding atopic dermatitis have taken place in the last 12 months.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 239948 239949 239950 question first answered 10/04/2019 13:36:32 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4056 label Biography information for Nic Dakin

1109188

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners: Bexley
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the average waiting time for patients to see their GP in Bexley has been for (a) non-emergency appointments and (b) emergency appointments in the last twelve months.
	tabling member constituency	Bexleyheath and Crayford
	tabling member printed	Sir David Evennett
	uin	239895
	answer	answer is ministerial correction date of answer 10/04/2019 answer text <p>Bexley Clinical Commissioning Group (CCG) currently only captures data from four of its 23 general practices due to interoperability issues with one of the clinical system suppliers. However, national roll out of a new system to share this data is expected this month, meaning the relevant data for the remaining practices in Bexley should be available from May 2019.</p><p> </p><p>The time between booking an appointment with a general practice and having the appointment, in days, for the practices where data is currently collected in Bexley CCG is presented in the attached table for the last available published date which was February 2019. A 12 month average from March 2018 - February 2019 has also been presented along with a comparison to the average across all appointments in England. NHS Digital’s ‘Appointments in General Practice’ data is published monthly with a two-month time lag.</p><p> </p><p>The appointments data does not differentiate between emergency and routine appointments in general practice and the ‘time from booking to appointment’ does not take into consideration that many patients will be appropriately booking ahead as part of the continuity of care they receive for long-term conditions.</p><p> </p><table><tbody><tr><td><p> </p></td><td><p>Bexley</p></td><td><p>England</p></td><td><p>Bexley</p></td><td><p>England</p></td></tr><tr><td><p> </p></td><td colspan="2"><p>February 2019</p></td><td colspan="2"><p>March 2018 to February 2019</p></td></tr><tr><td><p>Same Day</p></td><td><p>35.8%</p></td><td><p>42.3%</p></td><td><p>38.1%</p></td><td><p>42.2%</p></td></tr><tr><td><p>1 Day</p></td><td><p>6.2%</p></td><td><p>6.8%</p></td><td><p>6.8%</p></td><td><p>6.8%</p></td></tr><tr><td><p>2 to 7 Days</p></td><td><p>20.6%</p></td><td><p>19.8%</p></td><td><p>22.9%</p></td><td><p>20.1%</p></td></tr><tr><td><p>8 to 14 Days</p></td><td><p>20.1%</p></td><td><p>14.4%</p></td><td><p>17.2%</p></td><td><p>13.8%</p></td></tr><tr><td><p>15 to 21 Days</p></td><td><p>8.5%</p></td><td><p>7.6%</p></td><td><p>7.4%</p></td><td><p>7.4%</p></td></tr><tr><td><p>22 to 28 Days</p></td><td><p>5.8%</p></td><td><p>5.1%</p></td><td><p>4.7%</p></td><td><p>5.0%</p></td></tr><tr><td><p>More than 28 Days</p></td><td><p>2.9%</p></td><td><p>4.0%</p></td><td><p>3.0%</p></td><td><p>4.7%</p></td></tr><tr><td><p>Total</p></td><td><p>100.0%</p></td><td><p>100.0%</p></td><td><p>100.0%</p></td><td><p>100.0%</p></td></tr></tbody></table><p> </p><p>The time between booking an appointment with a general practice and having the appointment, in days, for all data available in Bexley CCG is presented above for the last published month February 2019 and as a 12 month average from March 2018 - February 2019 along with a comparison to the average across all appointments in England.</p><p>Notes:</p><ol><li>Data has only been able to be captured from up to four out of the 23 GP practices in Bexley due to interoperability issues with one of the clinical system suppliers.</li><li>NHS Digital currently only publish data from Egton Medical Information Systems (EMIS) and The Phoenix Partnership (TPP) practice systems but are working with other general practitioner (GP) systems to bring them on board in future developments.</li><li>There are several factors that drive the time from a booking to an appointment. This includes appointment availability at the practice, patient availability, the urgency of the appointment and GP advice.</li><li>The data does not differentiate between emergency and routine appointments in general practice.</li><li>The data does not include any information about the patients or clinical information.</li><li>The data in the response includes appointments with all healthcare professional types, including GPs and other practice staff.</li><li>Not all practices in England are included in the appointments in general practice publication, meaning the total number of appointments is not known.</li><li>Same day and next day bookings are of particular interest so are presented here separately. Further bookings are presented grouped by weeks.</li><li>The number of appointments that have already happened is provided as recorded in participating EMIS and TPP practices in England. The data presented only contains information which was captured on the GP practice systems. This limits the activity reported on and does not represent all work happening within a primary care setting.</li></ol><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/04/2019 13:34:29 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1198 label Biography information for Sir David Evennett

1109224

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Integrated Care Systems
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what comparative assessment he has made of the effectiveness of (a) Integrated Care Organisations and (b) pre-existing NHS England arrangements; and what assessment he has made of the effect of those (a) organisations and (b) arrangements on patient care.
	tabling member constituency	Tooting
	tabling member printed	Dr Rosena Allin-Khan
	uin	240061
	answer	answer is ministerial correction date of answer 10/04/2019 answer text <p>Integrated Care Organisations’ is not a term currently used by NHS England, so the answer below refers to Integrated Care Providers.</p><p> </p><p>‘Integrated Care Provider’ (ICP) is a term used to describe a provider that is responsible for the integrated provision of general practice, wider National Health Service and potentially local authority services, which enters into an ICP contract with the commissioner(s) of those services. The ICP would be a ‘lead’ provider organisation, and so would be contractually responsible for delivering integrated services for local people. An ICP is not a new type of legal entity, but simply the name for a provider organisation awarded an ICP contract. The ICP contract is itself a variant of the generic NHS Standard Contract (which is already used to commission a broad range of NHS services) and has been specifically designed to enable integration through a single contract that could be used to commission both primary medical services and other health and care services.</p><p> </p><p>There are not yet any ICPs in place in England. However, NHS England plans to study the effects of the first ICP contracts that come into being and share learning with others that may follow. Where a clinical commissioning group (CCG) proposes to use the ICP contract in future, proposals will be subject to successful completion of the Integrated Support and Assurance Process, managed by NHS England and NHS Improvement, before the ICP Contract is awarded.</p><p> </p><p>Further information about ICPs is available in NHS England’s package of consultation materials and response to consultation, which are available at the following link:</p><p> </p><p><a href="https://www.engage.england.nhs.uk/consultation/proposed-contracting-arrangements-for-icps/" target="_blank">https://www.engage.england.nhs.uk/consultation/proposed-contracting-arrangements-for-icps/</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/04/2019 13:43:36 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4573 label Biography information for Dr Rosena Allin-Khan

1109232

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Clinical Priorities Advisory Group
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans NHS England has to utilise the NICE Commissioning Support Programme for the development of national clinical policies not yet scheduled for review by the Clinical Priorities Advisory Group.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	239979
	answer	answer is ministerial correction date of answer 10/04/2019 answer text <p>There are several policy propositions currently being developed through the Commissioning Support Programme which will be considered by the Clinical Priorities Advisory group (CPAG) at future meetings.</p><p> </p><p>Members of the public will be able to attend the CPAG prioritisation meeting in May 2019, attendance being through a registration process.</p><p> </p><p>The use of patient impact reports is a part of a pilot which will be evaluated and considered by NHS England.</p><p> </p><p>The whole process of commissioning policy and service specification development has previously been consulted on and the documented process is published on the NHS England website at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/publication/methods-national-service-specifications/" target="_blank">https://www.england.nhs.uk/publication/methods-national-service-specifications/</a></p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 239980 239981 239982 question first answered 10/04/2019 13:49:01 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4131 label Biography information for Jim Shannon